Latest Breaking News On - Guillaume bayre - Page 1 : vimarsana.com

Enterome to Participate in the Jefferies Global Healthcare Conference

Enterome to Participate in the Jefferies Global Healthcare Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France generalNew yorkUnited statesChristelle dumoussaudGuillaume bayreWeid europeAshleyr robinsonHead of external communicationsLifesci advisorsMarriott marquisHealth scienceJefferies global healthcareChief executive officerChief financial officerJefferies global healthcare conference

Enterome Highlights High Complete Response Rate in Clinical Study of EO2463 for Indolent Non-Hodgkin Lymphoma at ASCO 2024

Enterome Highlights High Complete Response Rate in Clinical Study of EO2463 for Indolent Non-Hodgkin Lymphoma at ASCO 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesAshleyr robinsonJan fagerbergGuillaume bayreWeid europeLifesci advisorsHead of external communicationsHealth scienceDivision of hematologyAmerican society of clinical oncologyHighlights high complete response rateClinical studyIndolent non hodgkin lymphomaAmerican societyClinical oncology

Enterome to Present Clinical Data on EO2463 in B-cell Lymphoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Enterome to Present Clinical Data on EO2463 in B-cell Lymphoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalGuillaume bayreAshleyr robinsonWeid europeAmerican society of clinical oncologyHead of external communicationsLifesci advisorsHealth sciencePresent clinical dataB cell lymphomaClinical oncologyAnnual meetingVillasboas bisnetoMayo clinicHematologic malignancies

Enterome Appoints Industry Veteran Dr Peter Hirth to its Board of Directors

PARIS, Dec. 18, 2023 (GLOBE NEWSWIRE) Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liqui.

Baden wübergUnited statesFrance generalNew zealand generalNew zealandSan diegoTrex bioAshleyr robinsonWeid europeRogerj garceauGuillaume bayreK peter hirthHealth scienceResearch at boehringer mannheimLifesci advisorsHeidelberg university

Enterome s OncoMimics™ Immunotherapy EO2401 Significantly Improves Survival Rate in Recurrent Glioblastoma

Positive data from the ROSALIE Phase 1/2 trial presented at 2023 SNO Annual MeetingMedian survival of 14.5 months and 18-months survival rate of 4.

France generalBritish columbiaUnited kingdomAshleyr robinsonPierre belichardGuillaume bayreWeid europeDavid reardonHead of external communicationsHealth scienceSociety for neuroProfessor of medicine at harvard medical schoolOncology at dana farber cancer instituteLifesci advisorsAnnual meetingHarvard medical school